Lin, T. C., Chen, G. H., Yeh, C. C., Ke, H. L., Li, W. M., Tsai, Y. C., Wu, S. Y., Huang, C. Y., Chen, C. H., Lin, W. R., Chen, M., Lo, S. H., Pang, S. T., and Lin, P. H. (2024) No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy. Sci Rep 14, 17766
Lim, L. M., Lee, Y. C., Lin, T. W., Hong, Z. X., Hsu, W. C., Ke, H. L., Hwang, D. Y., Chung, W. Y., Li, W. M., Lin, H. H., Kuo, H. T., and Huang, A. M. (2024) NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas. Kaohsiung J Med Sci 40, 445-455
Tu, K. Y., Li, C. C., Li, W. M., Yeh, H. C., Ke, H. L., Wu, W. J., Chien, T. M., Wen, S. C., Wang, Y. C., and Lee, H. Y. (2024) Lipid Profiles Impact on the Oncologic Outcome of Upper Tract Urothelial Carcinoma. World J Oncol 15, 287-297
Huang, T. H., Li, W. M., Ke, H. L., Li, C. C., Wu, W. J., Yeh, H. C., Wang, Y. C., and Lee, H. Y. (2024) The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores. J Formos Med Assoc.
Liang, P. I., Wei, Y. C., Chen, H. D., Ma, Y. C., Ke, H. L.,Chien, C. C., and Chuang, H. W. (2024) TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma. KaohsiungJ Med Sci 40, 269-279
Wang, C.S., Lee, Y.C., Jhan, J.H., Li, W.M., Chang, L.L., Huang, A.M., Lin, H.H., Wu, Y.R., Hsu, W.C.*, and Ke, H.L.*, 2024. MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma. J Gene Med . 26: e3616.
Li, W.M., Chan, T.C., Wei, Y.C., Li, C.F., Ke, H.L., Wu, W.J., Hsu, C.C., Wang, S.C., Yeh, C.F., 2023. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis. Front Biosci (Landmark Ed) 28, 217.
Luo, H.L., Lee, Y.C., Chang,Y.L., Hsu, W.C., Wu, Y.T., Jhan, J.H., Lin, H.H., Wu, Y.R., Ke, H.L.*, and Liu, H.Y.*, 2023. MicroRNA-145-5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. J Cell Biochem . 124, 1324-1345.
Lee, M.R., Li, W.M., Li, C.C., Chou, Y.H., Wu, W.J., Juan,Y.S., Ke, H.L., Wen, S.C., Lee, H.Y., Chien, T.M., 2023. Cumulative sumanalysis of the learning curve of laparoendoscopic single-site robot-assisted radical prostatectomy. Asian J Surg. 46, 3614-3619.
Jhan, J.H., Ke, H.L., Liang, P.I., Hsu, W.C., Lee, Y.C., Lin, H.H., Wu, Y.R., Huang, A.M., Lee, H.Y., Yeh, H.C., Wu, W.J., Li, C.C., Li, W.M., 2023. High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas. Appl Immunohistochem Mol Morphol 31, 94-100.
Wu, K.H., Chang, C.H., Wu, H.C., Huang, S.K., Liu, C.L., Yang, C.K., Li, J.R., Tseng, J.S., Lin, W.R., Yu, C.C., Lo, C.W., Huang, C.Y., Chen, C.H., Tsai, C.Y., Cheng, P.Y., Jiang, Y.H., Lee, Y.K., Chen, Y.T., Yeh, T.C., Lin, J.T., Tsai, Y.C., Hsueh, T.Y., Chiang, B.J., Chiang, Y.D., Lin, W.Y., Jou, Y.C., Pang, S.T., Ke, H.L.*, 2022. Oncologic impact of delay between diagnosis and radical nephroureterectomy. Front Oncol 12, 1025668.
Lim, L.M., Chung, W.Y., Hwang,D.Y., Yu, C.C., Ke, H.L., Liang, P.I., Lin, T.W., Cheng, S.M., Huang, A.M., Kuo, H.T., 2022. Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation. J Transl Med 20, 324.
Yuan, C. H., Hsu, W. C., Huang, A. M., Yuan, B. C., Chen, I. H., Hsu, C. A., Chen, R. F., Chu, Y. M., Lin, H. H., and Ke, H. L*. (2022) MicroRNA-145-5p modulates Kruppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma. BMC Mol Cell Biol 23, 28
Yu, C. C., Chen, C. H., Hong, J. H., Ke, H. L., Li, W. M., Chung, S. D., Wu, W. C., Chen, Y. T., Jiang, Y. H., Lin, Y. H., Lin, W. Y., Wu, C. C., and Tsai, Y. C. (2022) Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group. Surg Endosc 36, 4342-4348
Lo, C. W., Li, W. M., Ke, H. L., Chang, Y. H., Wu, H. C., Chen, I. A., Lin, J. T., Huang, C. Y., Chen, C. H., Tseng, J. S., Lin, W. R., Jiang, Y. H., Lee, Y. K., Tsai, C. Y., Chung, S. D., Hsueh, T. Y., Chiu, A. W., Jou, Y. C., Cheong, I. S., Chen, Y. T., Chen, J. S., Chiang, B. J., Yu, C. C., Lin, W. Y., Wu, C. C., Chen, C. S., Weng, H. Y., and Tsai, Y. C. (2022) Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis. Front Oncol 12, 843715
Lin, T. W., Lee, H. Y., Yang, S. F., Li, C. C., Ke, H. L., Li, W. M., Li, C. Y., Tu, H. P., Wu, W. J., and Yeh, H. C. (2022) Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy. Ann Surg Oncol 29, 3306-3317
Lim, L. M., Chung, W. Y., Hwang, D. Y., Yu, C. C., Ke, H. L., Liang, P. I., Lin, T. W., Cheng, S. M., Huang, A. M., and Kuo, H. T. (2022) Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation. J Transl Med 20, 324
Li, W. M., Ke, H. L., Kuo, Y. H., Lai, H. Y., Chan, T. C., Hsing, C. H., Hsieh, K. L., Li, W. S., Chen, T. J., Wei, Y. C., Wu, W. J., Huang, S. K., and Li, C. F. (2022) High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma. Oncology
Lee, M. R., Ke, H. L., Huang, J. C., Huang, S. P., and Geng, J. H. (2022) Obesity-related indices and its association with kidney stone disease: a cross-sectional and longitudinal cohort study. Urolithiasis 50, 55-63
Lee, H. Y., Chang, C. H., Huang, C. P., Yu, C. C., Lo, C. W., Chung, S. D., Wu, W. C., Chen, I. A., Lin, J. T., Jiang, Y. H., Lee, Y. K., Hsueh, T. Y., Chiu, A. W., Chen, Y. T., Lin, C. M., Tsai, Y. C., Chen, W. C., Chiang, B. J., Huang, H. C., Chen, C. H., Huang, C. Y., Wu, C. C., Lin, W. Y., Tseng, J. S., Ke, H. L., and Yeh, H. C. (2022) Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study. Front Oncol 12, 791620
Ke, H. L., Li, C. C., Lee, H. Y., Tu, H. P., Wei, Y. C., Yeh, H. C., Wu, W. J., and Li, W. M. (2022) Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy. Cancers (Basel) 14
Ke, H. L., Lee, Y. C., Li, W. M., Wang, C. S., Hsu, W. C., Lin, H. H., Lee, Y. A., Jhan, J. H., Li, C. C., Yeh, H. C., Wu, W. J., and Huang, A. M. (2022) High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma. Appl Immunohistochem Mol Morphol 30, 304-310
Jhan, J. H., Hsu, W. C., Lee, Y. C., Li, W. M., Huang, A. M., Lin, H. H., Wang, C. S., Wu, Y. R., Li, C. C., Wu, W. J., and Ke, H. L*. (2022) MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1. Cancers (Basel) 14
Yeh, H. C., Li, C. C., Chien, T. M., Li, C. Y., Cheng, Y. C., Woldu, S. L., Robyak, H., Huang, C. N., Ke, H. L., Li, W. M., Lee, H. Y., Yeh, B. W., Yang, S. F., Tu, H. P., Sagalowsky, A. I., Raman, J. D., Singla, N., Margulis, V., Lotan, Y., Hsieh, J. T., and Wu, W. J. (2021) Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy. World J Urol 39, 491-500
Yeh, C. F., Chan, T. C., Ke, H. L., Chen, T. J., Wu, L. C., Lee, H. Y., Wei, Y. C., Wu, W. J., Li, C. F., and Li, W. M. (2021) Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma. Biomedicines 9
Wu, Y. R., Lee, Y. C., Li, W. M., Hsu, W. C., Lin, H. H., Chang, L. L., Huang, A. M., Jhan, J. H., Wu, W. J., Li, C. C., Lee, H. Y., Yeh, H. C., and Ke, H. L*. (2021) High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma. Pathol Int 71, 463-470
Wang, C. S., Guu, S. J., Wang, C. J., Yang, S. F., Ke, H. L., Lee, Y. C., and Jhan, J. H. (2021) A rare noncancerous but life-threatening tumor in urinary bladder. Clin Case Rep 9, 1683-1687
Su, Y. C., Wen, S. C., Li, C. C., Su, H. C., Ke, H. L., Li, W. M., Lee, H. Y., Li, C. Y., Yang, S. F., Tu, H. P., Wu, W. J., and Yeh, H. C. (2021) Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma. Biomedicines 9
Lin, C. H., Wu, W. J., Li, C. C., Ke, H. L., Jhan, J. H., and Wen, S. C. (2021) Comparison of different en bloc holmium laser enucleation of the prostate techniques to reduce the rate of postoperative transient urinary incontinence. J Int Med Res 49, 3000605211037488
Li, C. C., Chien, T. M., Lee, M. R., Lee, H. Y., Ke, H. L., Wen, S. C., Chou, Y. H., and Wu, W. J. (2021) Extraperitoneal Robotic Laparo-Endoscopic Single-Site Plus1-Port Radical Prostatectomy Using the da Vinci Single-Site Platform. J Clin Med 10
Lee, H. Y., Li, C. C., Li, W. M., Hsu, Y. L., Yeh, H. C., Ke, H. L., Yeh, B. W., Huang, C. N., Li, C. F., Kuo, P. L., and Wu, W. J. (2021) Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses. PeerJ 9, e11343
Lee, H. Y., Chan, E. O., Li, C. C., Leung, D., Li, W. M., Yeh, H. C., Chiu, P. K., Ke, H. L., Yee, C. H., Wong, J. H., Ng, C. F., Teoh, J. Y., and Wu, W. J. (2021) How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19? Urol Oncol 39, 733 e711-733 e716
Chien, T. M., Lee, H. Y., Singla, N., Margulis, V., Lotan, Y., Woldu, S. L., Huang, C. N., Li, C. C., Ke, H. L., Li, W. M., Li, C. Y., Huang, A. M., Yang, S. F., Tu, H. P., Wu, W. J., and Yeh, H. C. (2021) Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study. Cancers (Basel) 13
Chen, T. J., Chan, T. C., Li, W. S., Li, C. F., Ke, H. L., Wei, Y. C., Wu, W. J., and Li, W. M. (2021) Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma. Genes (Basel) 12
Chang, C. W., Ke, H. L., Lee, J. I., Lee, Y. C., Jhan, J. H., Wang, H. S., Shen, J. T., Tsao, Y. H., Huang, S. P., and Geng, J. H. (2021) Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study. J Pers Med 11
Yu, L. C., Chang, C. H., Huang, C. P., Huang, C. Y., Hong, J. H., Tai, T. Y., Weng, H. Y., Lo, C. W., Tsai, C. Y., Lee, Y. K., Tsai, Y. C., Hsueh, T. Y., Chen, Y. T., Chen, I. H., Chiang, B. J., Tseng, J. S., Wu, C. C., Lin, W. Y., Chien, T. M., Sheu, Z. L., Li, C. C., Ke, H. L., Li, W. M., Lee, H. Y., Wu, W. J., and Yeh, H. C. (2020) Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan. J Clin Med 9
Yeh, H. C., Margulis, V., Singla, N., Hernandez, E., Panwar, V., Woldu, S. L., Karam, J. A., Wood, C. G., Weizer, A. Z., Raman, J. D., Remzi, M., Rioux-Leclercq, N., Haitel, A., Roscigno, M., Bolenz, C., Bensalah, K., Li, C. C., Ke, H. L., Li, W. M., Lee, H. Y., Rapoport, L. M., Lotan, Y., Kapur, P., Shariat, S. F., Hsieh, J. T., and Wu, W. J. (2020) PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy. Urol Oncol 38, 496-505
Yeh, H. C., Li, C. C., Wen, S. C., Singla, N., Woldu, S. L., Robyak, H., Huang, C. N., Ke, H. L., Li, W. M., Lee, H. Y., Li, C. Y., Yeh, B. W., Yang, S. F., Tu, H. P., Shariat, S. F., Sagalowsky, A. I., Raman, J. D., Lotan, Y., Hsieh, J. T., Margulis, V., and Wu, W. J. (2020) Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma. J Clin Med 9
Wu, Y. H., Jhan, J. H., Ke, H. L., Tseng, S. I., Chang, Y. H., Yeh, H. C., Li, C. C., and Lee, Y. C. (2020) Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study. Int J Clin Pharm 42, 1433-1439
Li, W. M., Chan, T. C., Huang, S. K., Wu, W. J., Ke, H. L., Liang, P. I., Wei, Y. C., Shiue, Y. L., and Li, C. F. (2020) Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma. Front Oncol 10, 570340
Li, C. C., Chien, T. M., Huang, S. P., Yeh, H. C., Lee, H. Y., Ke, H. L., Wen, S. C., Chang, W. C., Juan, Y. S., Chou, Y. H., and Wu, W. J. (2020) Single-Site Sutureless Partial Nephrectomy for Small Exophytic Renal Tumors. J Clin Med 9
Hsu, W. C., Li, W. M., Lee, Y. C., Huang, A. M., Chang, L. L., Lin, H. H., Wu, W. J., Li, C. C., Liang, P. I., and Ke, H. L*. (2020) MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6. FASEB J 34, 5975-5992
Chen, H. W., Tang, J. Y., Chen, Y. C., Wu, W. J., Ke, H. L., and Li, C. C. (2020) Intensity modulation radiation therapy as alternative primary non-surgical treatment of upper tract urothelial carcinoma. Int J Urol 27, 266-268
Lee, H. Y., Chen, Y. J., Li, C. C., Li, W. M., Hsu, Y. L., Yeh, H. C., Ke, H. L., Huang, C. N., Li, C. F., Wu, W. J., and Kuo, P. L. (2019) Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches. Int J Med Sci 16, 93-105
Lee, H. Y., Chen, Y. J., Chang, W. A., Li, W. M., Ke, H. L., Wu, W. J., and Kuo, P. L. (2019) Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma-Next-Generation Sequencing and Bioinformatics Approaches. Medicina (Kaunas) 55
Jhan, J. H., Lee, Y. C., Li, W. M., Chang, L. L., Hsu, W. C., Lin, H. H., Liang, P. I., Hsu, Y. L., Wu, W. J., Lee, H. Y., Li, C. C., Yeh, H. C., and Ke, H. L*. (2019) The prognostic value of CSN6 expression in upper tract urothelial carcinomas. Kaohsiung J Med Sci 35, 559-565
Huang, Y. T., Li, C. C., Chou, Y. H., Ke, H. L., and Chen, C. Y. (2019) Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study. Int J Clin Pharm 41, 993-1003
Hsu, W. C., Lee, Y. C., Liang, P. I., Chang, L. L., Huang, A. M., Lin, H. H., Wu, W. J., Li, C. C., Li, W. M., Jhan, J. H., and Ke, H. L*. (2019) CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas. Dis Markers 2019, 2724948
Chen, Y. C., Chen, H. W., Chen, M. T., Huang, C. H., Li, C. C., Juan, Y. S., and Ke, H. L*. (2019) Severe prostate enlargement with severe lower urinary tract symptoms in poorly controlled acromegaly successfully treated with 5alpha-reductase inhibitors: A 15-year longitudinal case report. Low Urin Tract Symptoms 11, O218-O220
Chan, T. C., Li, C. F., Ke, H. L., Wei, Y. C., Shiue, Y. L., Li, C. C., Yeh, H. C., Lee, H. Y., Huang, S. K., Wu, W. J., and Li, W. M. (2019) High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas. Urol Oncol 37, 293 e211-293 e224
Lu, J. H., Liao, W. T., Lee, C. H., Chang, K. L., Ke, H. L., and Yu, H. S. (2018) DeltaNp63 promotes abnormal epidermal proliferation in arsenical skin cancers. Toxicol In Vitro 53, 57-66
Lee, H. Y., Yeh, H. C., Wu, W. J., He, J. S., Huang, C. N., Ke, H. L., Li, W. M., Li, C. F., and Li, C. C. (2018) The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence. World J Surg Oncol 16, 135
Lin, S. R., Yeh, H. C., Wang, W. J., Ke, H. L., Lin, H. H., Hsu, W. C., Chao, S. Y., Hour, T. C., Wu, W. J., Pu, Y. S., and Huang, A. M. (2017) MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. J Cell Biochem 118, 1563-1573
Liang, P. I., Yeh, B. W., Li, W. M., Chan, T. C., Chang, I. W., Huang, C. N., Li, C. C., Ke, H. L., Yeh, H. C., Wu, W. J., and Li, C. F. (2017) DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness. Oncotarget 8, 2995-3008
Li, W. M., Huang, C. N., Lee, Y. C., Chen, S. H., Lin, H. H., Wu, W. J., Li, C. C., Yeh, H. C., Chang, L. L., Hsu, W. C., and Ke, H. L*. (2017) Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma. Int J Med Sci 14, 1360-1367
Lee, Y. C., Wu, W. J., Lin, H. H., Li, W. M., Huang, C. N., Hsu, W. C., Chang, L. L., Li, C. C., Yeh, H. C., Li, C. F., and Ke, H. L*. (2017) Prognostic Value of Leptin Receptor Overexpression in Upper Tract Urothelial Carcinomas in Taiwan. Clin Genitourin Cancer 15, e653-e659
Lee, H. Y., Yeh, B. W., Chan, T. C., Yang, K. F., Li, W. M., Huang, C. N., Ke, H. L., Li, C. C., Yeh, H. C., Liang, P. I., Shiue, Y. L., Wu, W. J., and Li, C. F. (2017) Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract. Oncotarget 8, 47216-47229
Ke, H. L., Li, W. M., Lin, H. H., Hsu, W. C., Hsu, Y. L., Chang, L. L., Huang, C. N., Li, C. C., Chang, H. P., Yeh, H. C., Li, C. F., and Wu, W. J. (2017) Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma. Int J Med Sci 14, 578-584
Yeh, H. C., Huang, C. N., Li, C. C., Chang, L. L., Lin, H. H., Ke, H. L., Huang, A. M., Liang, P. I., Li, C. F., and Wu, W. J. (2016) Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer. World J Urol 34, 835-846
Yeh, H. C., Chien, T. M., Wu, W. J., Li, C. C., Li, W. M., Ke, H. L., Chou, Y. H., Wang, C. J., Huang, S. P., Li, C. F., Liang, P. I., and Huang, C. N. (2016) Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy? Urol Oncol 34, 337 e331-339
Tsai, M. C., Li, W. M., Huang, C. N., Ke, H. L., Li, C. C., Yeh, H. C., Chan, T. C., Liang, P. I., Yeh, B. W., Wu, W. J., Lim, S. W., and Li, C. F. (2016) DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study. Oncotarget 7, 78918-78931
Li, W. M., Wei, Y. C., Huang, C. N., Ke, H. L., Li, C. C., Yeh, H. C., Chang, L. L., Huang, C. H., Li, C. F., and Wu, W. J. (2016) Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas. J Surg Oncol 113, 700-707
Li, W. M., Huang, C. N., Ke, H. L., Li, C. C., Wei, Y. C., Yeh, H. C., Chang, L. L., Huang, C. H., Liang, P. I., Yeh, B. W., Chan, T. C., Li, C. F., and Wu, W. J. (2016) MCM10 overexpression implicates adverse prognosis in urothelial carcinoma. Oncotarget 7, 77777-77792
Li, C. C., Yeh, H. C., Lee, H. Y., Li, W. M., Ke, H. L., Hsu, A. H., Lee, M. H., Tsai, C. C., Chueh, K. S., Huang, C. N., Chou, Y. H., Li, C. F., and Wu, W. J. (2016) Laparoscopic partial nephrectomy without intracorporeal suturing. Surg Endosc 30, 1585-1591
Chien, T. M., Lu, Y. M., Geng, J. H., Huang, T. Y., Ke, H. L., Huang, C. N., Li, C. C., Chou, Y. H., Wu, W. J., and Huang, S. P. (2016) Predictors of Positive Bone Metastasis in Newly Diagnosed Prostate Cancer Patients. Asian Pac J Cancer Prev 17, 1187-1191
Cheng, Y. C., Huang, C. N., Wu, W. J., Li, C. C., Ke, H. L., Li, W. M., Tu, H. P., Li, C. F., Chang, L. L., and Yeh, H. C. (2016) The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma. Ann Surg Oncol 23, 343-351
Yeh, H. C., Jan, H. C., Wu, W. J., Li, C. C., Li, W. M., Ke, H. L., Huang, S. P., Liu, C. C., Lee, Y. C., Yang, S. F., Liang, P. I., and Huang, C. N. (2015) Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma. PLoS One 10, e0139624
Liang, P. I., Chen, W. T., Li, C. F., Li, C. C., Li, W. M., Huang, C. N., Yeh, H. C., Ke, H. L., Wu, W. J., and Chai, C. Y. (2015) Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma. J Clin Pathol 68, 1026-1032
Lee, H. Y., Li, C. C., Huang, C. N., Li, W. M., Yeh, H. C., Ke, H. L., Yang, K. F., Liang, P. I., Li, C. F., and Wu, W. J. (2015) INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. J Surg Oncol 111, 414-422
Lee, H. Y., Li, C. C., Huang, C. N., Ke, H. L., Li, W. M., Liang, P. I., Yang, S. F., Tu, H. P., Wu, W. J., and Yeh, H. C. (2015) Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location. Ann Surg Oncol 22, 1392-1400
Ke, H. L., Lin, J., Ye, Y., Wu, W. J., Lin, H. H., Wei, H., Huang, M., Chang, D. W., Dinney, C. P., and Wu, X. (2015) Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer. Ann Surg Oncol 22, 4104-4110
Ke, H. L., Lin, H. H., Li, W. M., Li, C. C., Chang, L. L., Lee, Y. C., Huang, C. N., and Wu, W. J. (2015) High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients. Am J Cancer Res 5, 2447-2454
Fan, E. W., Li, C. C., Wu, W. J., Huang, C. N., Li, W. M., Ke, H. L., Yeh, H. C., Wu, T. F., Liang, P. I., Ma, L. J., and Li, C. F. (2015) FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder. J Urol 194, 223-229
Wei, H., Ke, H. L., Lin, J., Shete, S., Wood, C. G., and Hildebrandt, M. A. (2014) MicroRNA target site polymorphisms in the VHL-HIF1alpha pathway predict renal cell carcinoma risk. Mol Carcinog 53, 1-7
Li, W. M., Wu, W. J., Li, C. C., Ke, H. L., Wei, Y. C., Yeh, H. C., Chou, Y. H., Huang, C. H., and Huang, C. N. (2013) The effect of tumor location on prognosis in patients with primary ureteral urothelial carcinoma. Urol Oncol 31, 1670-1675
Lee, Y. C., Wu, W. J., Li, W. M., Lin, H. H., Huang, C. N., Chai, C. Y., Chang, L. L., Lin, H. L., and Ke, H. L*. (2013) Prognostic value of p53 protein overexpression in upper tract urothelial carcinomas in Taiwan. Anticancer Res 33, 1091-1098
Ke, H. L., Chen, M., Ye, Y., Hildebrandt, M. A., Wu, W. J., Wei, H., Huang, M., Chang, D. W., Dinney, C. P., and Wu, X. (2013) Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis 34, 1006-1011
Chen, S. H., Wu, W. J., Tu, H. P., Li, W. M., Huang, C. N., Li, C. C., Lin, H. H., and Ke, H. L*. (2013) Glutathione S-transferase expression in upper urinary tract urothelial carcinomas: a Taiwan study. Asian Pac J Cancer Prev 14, 6475-6479
Wei, H., Kamat, A., Chen, M., Ke, H. L., Chang, D. W., Yin, J., Grossman, H. B., Dinney, C. P., and Wu, X. (2012) Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guerin. PLoS One 7, e38533
Lin, H. H., Ke, H. L., Wu, W. J., Lee, Y. H., and Chang, L. L. (2012) Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Urol Oncol 30, 177-181
Ke, H. L., Tu, H. P., Lin, H. H., Chai, C. Y., Chang, L. L., Li, W. M., Li, C. C., Lee, Y. C., Yeh, H. C., Wu, W. J., and Bau, D. T. (2012) Cyclooxygenase-2 (COX-2) up-regulation is a prognostic marker for poor clinical outcome of upper tract urothelial cancer. Anticancer Res 32, 4111-4116
Chang, W. S., Ke, H. L., Tsai, C. W., Lien, C. S., Liao, W. L., Lin, H. H., Lee, M. H., Wu, H. C., Chang, C. H., Chen, C. C., Lee, H. Z., and Bau, D. T. (2012) The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma. Anticancer Res 32, 3855-3860
Wu, H. C., Chang, C. H., Ke, H. L., Chang, W. S., Cheng, H. N., Lin, H. H., Wu, C. Y., Tsai, C. W., Tsai, R. Y., Lo, W. C., and Bau, D. T. (2011) Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in taiwan. Anticancer Res 31, 221-225
Lin, H. H., Ke, H. L., Hsiao, K. H., Tsai, C. W., Wu, W. J., Bau, D. T., and Chang, L. L. (2011) CCND1 1722 polymorphism and potential relevance to upper tract urothelial cancer. Anticancer Res 31, 1043-1047
Lin, H. H., Ke, H. L., Hsiao, K. H., Tsai, C. W., Wu, W. J., Bau, D. T., and Chang, L. L. (2011) Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan. Chin J Physiol 54, 196-202
Ke, H. L., Chang, L. L., Yang, S. F., Lin, H. H., Li, C. C., Wu, D. C., and Wu, W. J. (2011) Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urol Oncol 29, 703-709
Chou, Y. H., Li, C. C., Hsu, H., Chang, W. C., Liu, C. C., Li, W. M., Ke, H. L., Lee, M. H., Liu, M. E., Pan, S. C., and Wang, H. S. (2011) Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 27, 264-267
Yeh, H. C., Huang, C. H., Yang, S. F., Li, C. C., Chang, L. L., Lin, H. H., Ke, H. L., Wei, Y. C., and Wu, W. J. (2010) Nuclear factor-kappaB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma. BJU Int 106, 1223-1229
Wu, W. J., Ke, H. L., Yang, Y. H., Li, C. C., Chou, Y. H., and Huang, C. H. (2010) Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol 183, 56-61
Liu, C. C., Juan, H. C., Lee, Y. C., Wu, W. J., Wang, C. J., Ke, H. L., Li, W. M., Yeh, H. C., Li, C. C., Chou, Y. H., Huang, C. H., and Huang, S. P. (2010) The impact of physical health and socioeconomic factors on sexual activity in middle-aged and elderly Taiwanese men. Aging Male 13, 148-153
Lin, H. H., Ke, H. L., Huang, S. P., Wu, W. J., Chen, Y. K., and Chang, L. L. (2010) Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol 28, 597-602
Li, W. M., Shen, J. T., Li, C. C., Ke, H. L., Wei, Y. C., Wu, W. J., Chou, Y. H., and Huang, C. H. (2010) Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57, 963-969
Liu, C. C., Wu, W. J., Lee, Y. C., Wang, C. J., Ke, H. L., Li, W. M., Hsiao, H. L., Yeh, H. C., Li, C. C., Chou, Y. H., Huang, C. H., and Huang, S. P. (2009) The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med 6, 936-946
Li, W. M., Li, C. C., Ke, H. L., Wu, W. J., Huang, C. N., and Huang, C. H. (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182, 451-458; discussion 458
Lee, Y. C., Wu, W. J., Liu, C. C., Wang, C. J., Li, W. M., Huang, C. H., Yeh, H. C., Ke, H. L., and Huang, S. P. (2009) The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 6, 3158-3165
Shiea, J., Cho, Y. T., Lin, Y. H., Chang, C. W., Lo, L. H., Lee, Y. C., Ke, H. L., Wu, W. J., and Wu, D. C. (2008) Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria. Rapid Commun Mass Spectrom 22, 3754-3760
Li, C. C., Chang, T. H., Wu, W. J., Ke, H. L., Huang, S. P., Tsai, P. C., Chang, S. J., Shen, J. T., Chou, Y. H., and Huang, C. H. (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54, 1127-1134
Ke, H. L., Wei, Y. C., Yang, S. F., Li, C. C., Wu, D. C., Huang, C. H., and Wu, W. J. (2008) Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract. Int J Urol 15, 200-205
Hsiao, H. L., Yeh, H. C., Chang, T. H., Ke, H. L., Lin, H. C., Wu, W. J., Huang, C. H., and Lee, Y. C. (2008) Renal collecting duct carcinoma and concomitant bladder urothelial carcinoma: a case report. Kaohsiung J Med Sci 24, 157-162
Yeh, H. C., Yang, S. F., Ke, H. L., Lee, K. S., Huang, C. H., and Wu, W. J. (2007) Renal cell carcinoma presenting with skull metastasis: a case report and literature review. Kaohsiung J Med Sci 23, 475-479
Wu, I. C., Wang, S. W., Yang, Y. C., Yu, F. J., Kuo, C. H., Chuang, C. H., Lee, Y. C., Ke, H. L., Kuo, F. C., Chang, L. L., Wang, W. M., Jan, C. M., and Wu, D. C. (2006) Comparison of a new office-based stool immunoassay and (13)C-UBT in the diagnosis of current Helicobacter pylori infection. J Lab Clin Med 147, 145-149
Wu, D. C., Wu, I. C., Wang, S. W., Lu, C. Y., Ke, H. L., Yuan, S. S., Wang, Y. Y., Chang, W. H., Wang, T. E., Bair, M. J., and Kuo, F. C. (2006) Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication. Diagn Microbiol Infect Dis 56, 373-378
Lin, H. C., Wu, W. J., Ke, H. L., and Huang, C. H. (2006) Bladder leiomyoma presenting as voiding dysfunction: a case report. Kaohsiung J Med Sci 22, 154-157
Lin, H. C., Shih, P. M., Chang, T. H., Ke, H. L., Wu, W. J., and Huang, C. H. (2006) Successful thrombolytic therapy for bilateral renal infarction: a case report. Kaohsiung J Med Sci 22, 410-414
Lin, H. C., Liu, C. C., Kang, W. Y., Ke, H. L., Li, C. C., Wu, W. J., and Huang, C. H. (2006) Huge aggressive angiomyxoma: a case report and literature review. Kaohsiung J Med Sci 22, 301-304
Ke, H. L., Lin, H. Y., Jang, M. Y., and Wu, W. J. (2006) Hair as the nidus for bladder calculi formation complicating suprapubic cystostomy catheterization: a case report. Kaohsiung J Med Sci 22, 243-246
Hsiao, H. L., Wu, W. J., Chang, M. Y., Ke, H. L., and Huang, C. H. (2006) Unusual case of multilocular cystic nephroma treated with nephron sparing technique: a case report. Kaohsiung J Med Sci 22, 515-518
Li, W. M., Wu, W. J., Ke, H. L., Chai, C. Y., Chou, Y. H., and Huang, C. H. (2005) Fibroepithelial polyps causing ureteropelvic junction obstruction in a child. Kaohsiung J Med Sci 21, 282-285
Ke, H. L., Hsiao, H. L., Guh, J. Y., Liu, C. S., Huang, C. H., and Wu, W. J. (2005) Primary intrarenal lipoma: a case report. Kaohsiung J Med Sci 21, 383-386
Su, C. M., Wu, W. J., Lee, Y. C., Ke, H. L., Chou, Y. H., and Huang, C. H. (2004) Spontaneous dissecting aneurysm of the renal artery: a case report. Kaohsiung J Med Sci 20, 609-611
Su, C. M., Lee, Y. C., Wu, W. J., Ke, H. L., Chou, Y. H., and Huang, C. H. (2004) Acute necrotizing ureteritis with obstructive uropathy following instillation of silver nitrate in chyluria: a case report. Kaohsiung J Med Sci 20, 512-515
Wu, I. C., Ke, H. L., Lo, Y. C., Yang, Y. C., Chuang, C. H., Yu, F. J., Lee, Y. C., Jan, C. M., Wang, W. M., and Wu, D. C. (2003) Evaluation of a newly developed office-based stool test for detecting Helicobacter pylori: an extensive pilot study. Hepatogastroenterology 50, 1761-1765
Chen, C. K., Li, C. C., Ke, H. L., Chou, Y. H., Huang, C. H., and Shih, M. C. (2003) Double J stent forgotten for 7 years: a case report. Kaohsiung J Med Sci 19, 84-87

All Post

The latest information in the laboratory